{"version":"1.0","provider_name":"Voisins de l'UE","provider_url":"https:\/\/www.eumedbridge.eu\/fr\/","author_name":"Nidhal Battikh","author_url":"https:\/\/www.eumedbridge.eu\/fr\/author\/nidhal_admin\/","title":"Les cannabino\u00efdes de synth\u00e8se en Europe \u2013 Examen - Voisins de l'UE","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"gDKXR2PmH5\"><a href=\"https:\/\/www.eumedbridge.eu\/fr\/publication\/les-cannabinoides-de-synthese-en-europe-examen\/\">Les cannabino\u00efdes de synth\u00e8se en Europe \u2013 Examen<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.eumedbridge.eu\/fr\/publication\/les-cannabinoides-de-synthese-en-europe-examen\/embed\/#?secret=gDKXR2PmH5\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Les cannabino\u00efdes de synth\u00e8se en Europe \u2013 Examen\u00a0\u00bb &#8212; Voisins de l&#039;UE\" data-secret=\"gDKXR2PmH5\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.eumedbridge.eu\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2022\/03\/cann.png","thumbnail_width":358,"thumbnail_height":529,"description":"Ce rapport\u00a0pr\u00e9sente un examen technique de l\u2019ensemble des connaissances actuelles sur les cannabino\u00efdes de synth\u00e8se\u00a0qui sont surveill\u00e9s par le syst\u00e8me d\u2019alerte pr\u00e9coce de l\u2019UE. L\u2019objectif de ce rapport est de renforcer la prise de conscience par rapport aux cannabino\u00efdes de synth\u00e8se en Europe\u00a0et d\u2019aider les parties prenantes \u00e0 se pr\u00e9parer et \u00e0 r\u00e9pondre aux menaces [&hellip;]"}